News
Dispex are now members of The CPD Certification Service
Please keep an eye on our blog for further details!
Class 3 Medicines Recall: Martindale Pharma, an Ethypharm Group Company Methadone 5mg Tablets / Physeptone 5mg Tablets, EL (21)A/31
Source: MHRA/ Gov.uk 22.11.21 Martindale Pharma is recalling the below batch of Methadone 5mg tablets as a precautionary measure due to the discolouration of the PVdC film in a small...
Class 2 Medicines Recall: SANTEN Oy (trading as Santen UK Limited) and parallel distributor, IKERVIS 1 mg/mL eye drops, emulsion and VERKAZIA 1 mg/mL eye drops, emulsion, EL (21)A/30
Source: MHRA Gov.uk 18/11/21 SANTEN Oy (trading as Santen UK Limited) are recalling the above batches of products as a precautionary measure due to detection of particles/crystals of the active...
COVID-19 vaccination in children and young people aged 16 to 17 years: JCVI statement, November 2021
Source: DHSC/ Gov.uk 15 November 2021 This statement sets out further advice on the offer of second doses of COVID-19 vaccine to children and young people aged 16 to 17...
Minimise transmission risk of CJD and vCJD in healthcare settings
Source: DHSC –Updated: 18 November 2021, Change made: Updated part 3: ‘Laboratory containment and control measures’. Guidance produced by the ACDP TSE risk management subgroup aims to help minimise the...
Class 4 Medicines Defect Information: Slenyto 1 mg and 5mg prolonged-release tablets – distributed by Flynn Pharma Ltd, EL (21)A/29
Source: MHRA / Gov.uk Flynn Pharma Ltd, distributors of Slenyto 1 mg and 5mg prolonged release tablets would like to notify you of an error with the patient information leaflets...
Brand Comparison Updates- LABA + ICS Inhalers
Brand Comparison Updates The Brand Comparisons for Combination LABA + ICS Inhalers have been updated with the latest Discounts available. Members can click here to login and view. Each month we add to our...
2022 Tutorial Schedule
New Schedule We understand that your protected learning time may still be limited, as we continue to live through the pandemic, for this reason we have decided to continue...
Investment and impact fund – inhaler prescribing
Source: NHSnetworks Four new indicators in the investment and impact fund (IIF) will support primary care teams in reducing carbon emissions from inhalers. Primary care networks (PCNs) are now rewarded...
Prescribing Costs in Hospitals and the Community – England 2020/21
Source: NHSBSA 11/11/21 Summary This publication aims to explore the costs of medicines prescribed within both primary and secondary care in England. This publication is an experimental Official Statistic...
Digital CD registers: not made the digital switch!? Attend our FREE webinar!!
Not made the digital switch!? Attend our free webinar to hear the why and how! DispexCD is fully legally compliant and supports NICE best practice Multiple layers of security &...
2022 NHSBSA Webinar Dates
Batch Submission and Switching Presented by Mark Gibbon, Pharmaceutical Technical Analyst. Mark works with BSA processing staff/contractors enabling accurate reimbursement This Webinar will offer clear guidance through the end of...
